Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
1
x
$
0.00
Asenapine in the Treatment of Bipolar Depression
1
x
$
30.00
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
1
x
$
30.00
View Cart
Checkout
Home
Schizophrenia and Valproate
“Treatment with Olanzapine: Early Predictors of Weight Gain Risk” has been added to your cart.
View cart
Schizophrenia and Valproate
$
30.00
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
Schizophrenia and Valproate quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Category:
VOL 37 Supplement No. 2
Tags:
aggression
,
divalproex-sodium
,
leslie-citrome
,
pharmacotherapy
,
schizophrenia
,
schizophrenia-and-valproate
,
valproate
Description
Description
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
7-PB_VOL-37-SUPPL-2
Related products
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
$
30.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Takefumi Suzuki – Treatment Target in Schizophrenia: A Critical Review and a Clinical Suggestion
$
30.00
Add to cart
Details
Page load link
Go to Top